Related Experiment Video
Updated: Jul 10, 2026
09:33
Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
New molecular targets in malignant gliomas
John F de Groot1, Mark R Gilbert
1Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Current Opinion in Neurology
|November 10, 2007
Summary
Identifying new molecular targets in neurooncology is crucial for treating malignant gliomas. Combination therapies and molecular profiling are key to advancing clinical practice for these brain tumors.
Area of Science:
- Neuro-oncology
- Molecular biology
- Cancer research
Background:
- Malignant gliomas involve complex molecular pathways driving tumor transformation and progression.
- Understanding signaling cascades is essential for targeting sustained proliferation, angiogenesis, invasion, and apoptosis resistance.
Purpose of the Study:
- To update on novel molecular targets in neuro-oncology.
- To discuss the translation of these targets into clinical practice.
Main Methods:
- Review of basic research on molecular pathways in glioma.
- Analysis of clinical studies on targeted therapies.
- Exploration of advances in oncogenomics, proteomics, and functional genomic screens.
Main Results:
- Basic research reveals numerous molecular targets for glioma.
- Single targeted therapies have shown disappointing results, necessitating combination trials.
- An increasing number of potential combination treatments require innovative trial designs and patient selection.
Conclusions:
- Technological advances facilitate rapid identification of critical targets for tumor growth arrest.
- Biomarkers are needed to tailor therapies for individual malignant glioma patients based on tumor molecular profiles.
